Neosil Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.7M

  • Investors
  • 1

Neosil General Information

Description

Developer of dermatology-focused specialty pharmaceutical products. The company has developed core topical anti-infective technology which provides broad anti-microbial activity, long duration of activity and formulation flexibility.

Contact Information

Website
www.neosil.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5980 Horton Street
  • Suite 525
  • Emeryville, CA 94608
  • United States
+1 (510)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 5980 Horton Street
  • Suite 525
  • Emeryville, CA 94608
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neosil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Oct-2008 $6.7M Completed Product Development
2. Mezzanine 15-May-2007 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Oct-2006 $32.1M $32.1M Completed Product Development
To view Neosil’s complete valuation and funding history, request access »

Neosil Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Neosil’s complete cap table history, request access »

Neosil Patents

Neosil Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050249818-A1 Polycationic antimicrobial therapeutic Inactive 03-May-2004
WO-2005115417-A2 Polycationic antimicrobial therapeutic Inactive 03-May-2004
WO-2005115417-A3 Polycationic antimicrobial therapeutic Inactive 03-May-2004 A61K31/785

Neosil Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Burrill & Co Merchant Banking Firm Minority
MPM BioImpact Venture Capital Minority
Shalon Ventures Venture Capital Minority
To view Neosil’s complete investors history, request access »

Neosil FAQs

  • When was Neosil founded?

    Neosil was founded in 2003.

  • Where is Neosil headquartered?

    Neosil is headquartered in Emeryville, CA.

  • What industry is Neosil in?

    Neosil’s primary industry is Pharmaceuticals.

  • Is Neosil a private or public company?

    Neosil is a Private company.

  • What is the current valuation of Neosil?

    The current valuation of Neosil is .

  • What is Neosil’s current revenue?

    The current revenue for Neosil is .

  • How much funding has Neosil raised over time?

    Neosil has raised $34.2M.

  • Who are Neosil’s investors?

    Burrill & Co, MPM BioImpact, and Shalon Ventures have invested in Neosil.

  • When was Neosil acquired?

    Neosil was acquired on 20-Oct-2008.

  • Who acquired Neosil?

    Neosil was acquired by Peplin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process